Researchers found that a cognitive-behavioral sleep therapy intervention helps adolescent night owls combat depression by aligning their natural sleep rhythms with daily responsibilities.
The management strategy could become an effective nocturia treatment—one that extends beyond the bladder and doesn't run the risk of side effects.
Nox Health recently agreed to pay $3.9 million to acquire the prescription digital therapeutic for chronic insomnia from Pear Therapeutics in its bankruptcy auction.
Nox Health Group is set to acquire Pear Therapeutics’ Somryst after being selected as the successful bidder at Pear’s bankruptcy auction last week.
Read More
Teach patients these relaxation exercises as part of their insomnia therapy.
Read More
The COVID-19 pandemic offered researchers a rare opportunity to see the effects of a potentially distressing global event on people with sleep reactivity, that is, those who are vulnerable to stress-related sleep disturbances.
Read More
Previous research has shown that weighted blankets may ease insomnia in humans, but the underlying mechanisms of how the blankets could impact sleep are not fully understood.
Read More
Jennifer L. Martin, PhD, speaks about the challenges faced by people with insomnia disorder in accessing CBT-I and pharmaceuticals, as well as posits solutions.
Read More
A paper details a health economic analysis of Somryst, including changes in healthcare resource use, associated costs, and insomnia severity.
Read More
A clinical psychologist describes how a few pieces of practical advice can help seniors get the best possible sleep.
Read More
ResMed has acquired Leipzig, Germany-based health tech company mementor; the deal was completed on August 1.
Read More
Within the next 3 to 5 years, we’ll see AI-driven technologies launch on the therapy side—driving a personalized sleep medicine revolution.
Read More
Insomnia is linked with anxiety and depression, and a clinical trial evaluates the impact of Somryst on these comorbidities.
Read More
Hundreds of thousands of insomnia patients will be offered digital cognitive behavioral therapy via the app Sleepio instead of sleeping pills.
Read More
Exactly how, when, and for how long a person with narcolepsy should nap to manage their disorder varies. Sleep physicians, patients, and advocates detail the nuances of how to navigate scheduled daytime sleep.
Read More
Two abstracts presented at World Sleep 2022 provide data on Somryst’s efficacy at six months and on its use in older adults.
Read More
By targeting insomnia and effectively treating it with CBT-I, depression can be effectively prevented by over 50% in community dwelling older adults with insomnia.
Read More
The new HCPCS code for Somryst encompasses “Prescription Digital Behavioral Therapy, FDA Cleared, per Course of Treatment.”
Read More